Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Julphar
Colorcon
Daiichi Sankyo
Merck
Moodys
UBS
McKesson
Dow

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018587

« Back to Dashboard

NDA 018587 describes WYTENSIN, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the WYTENSIN profile page.

The generic ingredient in WYTENSIN is guanabenz acetate. There are six drug master file entries for this compound. Additional details are available on the guanabenz acetate profile page.
Summary for 018587
Tradename:WYTENSIN
Applicant:Wyeth Ayerst
Ingredient:guanabenz acetate
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018587

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 4MG BASE
Approval Date:Sep 7, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 8MG BASE
Approval Date:Sep 7, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 16MG BASE
Approval Date:Sep 7, 1982TE:RLD:No

Expired US Patents for NDA 018587

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-003 Sep 7, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-001 Sep 7, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-002 Sep 7, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Johnson and Johnson
Healthtrust
Fish and Richardson
Merck
US Army
Daiichi Sankyo
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.